Projektförderungen

Deutsche Forschungsgemeinschaft
     -   "Corticosteroid receptor-mediated control of endocrine adipocyte function", 2007-2009
     -   "Neurohumoral regulation of adipose tissue function", 2004-2006
     -   "Regulation of energy homeostasis and insulin resistance by the sympathetic nervous 
          system, leptin, and insulin", 2000-2003
     -   "Crosstalk between adrenergic and insulin signaling systems", 1997-1999

Bundesministerium für Bildung und Forschung
     -   "Adipose transdifferentiation and mineralocorticoid receptor modulation", 2008-2010
          Teilprojekt im Kompetenznetz Adipositas

Alexander von Humboldt-Stiftung
     -   "Incretin crosstalk with adipose tissue", Feodor-Lynen-Fellowship, 2004-2007

Deutsche Diabetes Gesellschaft
     -   "Molecular mechanisms of insulin resistance and obesity", 2000-2002

Translationale Forschungsförderung durch die Industrie
     -   "Charakterisierung differentieller Fettgewebsdepotfunktionen"
          Beiersdorf, Exp. Forschung, Hamburg, Deutschland, 2007-2008
     -   "Molecular And Functional Analyses Using A Native Knock-Out Cell System For Cb-1
          And Cb2 Cannabinoid Receptors"
          Aventis-Sanofi, Research and Development, Paris & Berlin, France & Germany, 
          2006-2007
     -   "The Endocannabinoid-System: Molecular and Clinical Target for Controlling Metabolic & 
          Endocrine Fat Cell Function"
          Aventis-Sanofi, Research and Development, Paris & Berlin, France & Germany, 
          2006-2007
     -   "Modulation of Adipocyte Function by Incretins, DPP-IV, and DPP-IV Inhibitors: Clinical 
          Targets of Drug Development"
          Novartis, Biomedical Research, Cambridge, USA, 2004-2006
     -   "Atorvastatin interaction with adipose tissue function"
          Pfizer, Research & Development, New York, USA, 2004-2005

Medizinische Fakultät der Universität Lübeck
     -   "Regulation der Adipogenese durch das Inkretin GIP", 2007-2008
     -   "Regulation der Fettgewebsfunktion in vivo", 2003-2005
     -    Schwerpunktförderung "Glukose und Gehirn", 2002-2004
     -    Schwerpunktförderung "Metabolisches Syndrom", 2000-2002
     -   "Mechanismen sympatho-adrenerger Regulation des Energiestoffwechsels",
          1999-2000